Showing results (71-80 of 238) with videos related to

Sort By:
Pageof 24
Cancer Research|December 4, 2002
Missense mutations of the BRAF gene in human lung adenocarcinomaKatsuhiko Naoki, Tzu-Hsiu Chen, William G Richards, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 7, 2011
FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survivalVictor H Gerbaudo, Marcelo Mamede, Beatrice Trotman-Dickenson, et al.
Surgical Endoscopy|May 20, 2024
Quantitative assessment of the troCarWash™ system for automated laparoscopic camera cleaningMaaz Ahmed, Ashok Gowda, Fatemeh Alavi Naini, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 24, 2010
Prevalence of in vitro chemotherapeutic drug resistance in primary malignant pleural mesothelioma: result in a cohort of 203 resection specimensAneil A Mujoomdar, Tamara R Tilleman, William G Richards, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 13, 2020
Safety of robotic first rib resection for thoracic outlet syndromeBryan M Burt, Nihanth Palivela, Davut Cekmecelioglu, et al.
The Annals of Thoracic Surgery|April 4, 2017
A Meta-Analysis of Postoperative Radiotherapy for Thymic CarcinomaMasatsugu Hamaji, Rohan M Shah, Syed Osman Ali, et al.
Oncoimmunology|November 20, 2019
Predictors of benefits from frontline chemoimmunotherapy in stage IV non-small-cell lung cancer: a meta-analysisHazem E El-Osta, Frank E Mott, Bryan M Burt, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 25, 2003
A prognostic test for adenocarcinoma of the lung from gene expression profiling dataGavin J Gordon, William G Richards, David J Sugarbaker, et al.
The Annals of Thoracic Surgery|February 20, 2007
Unusual case of hemoptysis 13 years after bilobectomySubroto Paul, Siva Raja, Stacey Su, et al.
Human Immunology|July 22, 2008
Circulating HLA-DR(+) natural killer cells have potent lytic ability and weak antigen-presenting cell functionBryan M Burt, George Plitas, Hoang M Nguyen, et al.
Pageof 24